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OBJECTIVE: Cancer patients frequently require admission to intensive care unit. However, there are a few data
regarding predictive factors for mortality in this group of patients. The aim of this study was to evaluate whether
arterial lactate or standard base deficit on admission and after 24 hours can predict mortality for patients with cancer.
METHODS: We evaluated 1,129 patients with severe sepsis, septic shock, or postoperative after high-risk surgery.
Lactate and standard base deficit collected at admission and after 24 hours were compared between survivors and
non-survivors. We evaluated whether these perfusion markers are independent predictors of mortality.
RESULTS: There were 854 hospital survivors (76.5%). 24 h lactate.1.9 mmol/L and standard base deficit , -2.3 were
independent predictors of intensive care unit mortality. 24 h lactate .1.9 mmol/L and 24 h standard base deficit
, -2.3 mmol/Lwere independent predictors of hospital death.
CONCLUSION: Our findings suggest that lactate and standard base deficit measurement should be included in the
routine assessment of patients with cancer admitted to the intensive care unit with sepsis, septic shock or after high-
risk surgery. These markers may be useful in the adequate allocation of resources in this population.
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INTRODUCTION
Over the last decades, management of cancer patients has
changed significantly, resulting in significant improvements
in survival rates.1 While admissions to intensive care units
(ICU) are frequently required, admission criteria are often
difficult to be defined.2,3
Due to the lack of definitive predictive factors for mortality
in these patients, an ICU trial was proposed and conducted by
Lecuyer and colleagues4 suggesting that treatment limitation
decisions should be considered after at least six days of
complete management, when organ dysfunction scores could
differentiate the survivors from the non-survivors.
A multicenter European study, the SOAP study,3 found
that patients with hematologic malignancies and solid
tumors had a 29% hospital mortality rate. The most
significant outcome predictors were higher Simplified Acute
Physiology Score (SAPSII) and the need for mechanical
ventilation. In a recent multicenter and prospective study
with 717 patients with cancer admitted over a two-month
period into Brazilian ICUs,1 Soares and colleagues found that
mortality was associated with the length of hospital days
before ICU admission, the degree of organ dysfunction, the
status performance, the need for mechanical ventilation and
recurrent or progressing active malignancy.1
Lactate and standard base deficit (SBD), measured at
admission and within the first days of the ICU stay, are
important outcome markers in critically ill patients.5-8 However,
there have been no studies evaluating serum lactate levels and
SBD as predictive factors of mortality in patients with cancer.
The aim of this study was to evaluate whether arterial
lactate levels or SBD deficit taken on admission and after
24 h can predict ICU and hospital mortality for patients
with cancer admitted to the ICU.
METHODS
Study Design
Following approval by the institutional Medical Ethics
Committee, this prospective observational study was
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performed at the medical-surgical ICU of the Cancer
Institute do Estado de Sao Paulo, an oncology reference
hospital linked to the University of Sao Paulo. This is a
closed 44-bed ICU that admits 1,500 to 2,000 patients per
year, with approximately 60% postoperative and 40%
medical patients, and a global ICU mortality rate of
approximately 25%.9
We evaluated all patients admitted from August 2008 to
July 2010. Patients were considered eligible for the study if
they had a diagnosis of severe sepsis or septic shock
according to the current definition,11 with less than 24 hrs of
sepsis-related organ dysfunction or if they were at immedi-
ate postoperative of high risk surgery, defined as emergency
surgical procedures or elective prolonged surgery (.
3 hours).11,12 Patients were excluded if their ICU stay was
less than 24 hours or if palliative care was defined at the
time of admission. Data were prospectively collected daily
until hospital discharge or death, including age, gender,
medical/surgical status, oncologic diagnosis, status of
neoplasm, comorbidities, diagnosis for ICU admission,
and performance status (Karnofsky scale). Clinical and
laboratory data for the SAPS II and for the Acute Physiology
and Chronic Health Evaluation II score (APACHE II) were
recorded using the worst value within the first 24 hours
after ICU admission.13,14 The need for mechanical ventila-
tion, renal replacement therapy (RRT) or vasopressor agents
was recorded. Serum lactate and SBD were collected at
admission, after 24 hours and after an intervention invol-
ving a fluid challenge, use of inotropic agents or vasopres-
sors. The SBD and arterial lactate levels were obtained from
sampled arterial blood collected through an arterial line at
the same time of central venous blood samples. The central
venous catheter positions were previously checked. All
blood samples were analyzed in an AVL Omni Roche gas
analyzer (Basel, Switzerland). Standard base deficit was
calculated according to the Siggaard-Andersen (Van Slyke)
equation. The serum lactate level and SBD collected at
admission (0 h) and after 24 hours (24 h) were compared
between survivors and non-survivors through mean values
and subgroup analysis: lactate ,2, 2 to 4 and .4 mmol/L
and SBD ,-10, -10 to -4 and .-4 mmol/L. The intensive
treatment of patients was done according to the Surviving
Sepsis Campaign guidelines.10 We evaluated whether
arterial lactate and SBD were independent predictors of
ICU and hospital mortality.
Statistical Analysis
All data were analyzed using SPSS version 18 (SPSS, Inc.,
Chicago, IL, USA). Data were considered normal using the
Kolmogorov-Smirnov test. Results are expressed as means
with 95% confidence intervals (CIs) or medians with
interquartile ranges (IQRs). Single medians between the
groups were compared using the Mann-Whitney U test, and
categorical data were compared using a chi-square analysis.
We used analysis of variance for repeated measures to
analyze levels of lactate and base deficit at 0 h and 24 h
between the survivor and non-survivor groups.
A forward multiple logistic regression analysis was
performed to estimate predictive factors for ICU mortality.
Table 1 - Demographic and clinical characteristics of the patients and their outcomes.
Variable All patients Survivors Non-Survivors p-value
(N=1129) (N=864) (N =265)
Age (years), mean (95%CI) 61 (60 to 62) 61 (60 to 62) 61 (59 to 63) 0.708
Male gender 615 (54.5%) 474 (54.9%) 141 (53.2%) 0.636
APACHE II score 15 (11 to 23) 12 (9 to 18) 24 (18 to 28) ,0.001
SAPS II score, median (IQR) 38 (24 to 53) 30 (21 to 40) 57 (43 to 78) ,0.001
Type of Admission
Medical 625 (55.4%) 394 (45.6%) 231 (87.2%) ,0.001
Sepsis 400 (64%) 294 (74.6%) 106 (45.9%) ,0.001
Septic shock 225 (36%) 100 (25.4%) 125 (54.1%)
Surgical 504 (44.6%) 470 (54.4%) 34 (12.8%)
Gastrointestinal 162 (32.1%) 144 (30.6%) 18 (52.9%) 0.007
Thoracic 34 (6.7%) 29 (6.2%) 5 (14.7%) 0.055
Urologic 117 (23.2%) 111 (23.6%) 6 (17.6%) 0.426
Gynecologic 63 (12.5%) 62 (13.2%) 1 (2.9%) 0.081
Other 128 (25.4%) 124 (26.4%) 4 (11.8%) 0.059
Type of cancer
Locoregional solid tumor 777 (68.8%) 628 (72.7%) 149 (56.2%) ,0.001
Metastatic solid tumor 210 (18.6%) 146 (16.9%) 64 (24.2%)
Haematological malignancies 142 (12.6%) 90 (10.4%) 52 (19.6%)
Karnofski, median (IQR) 80 (65 to 90) 80 (70 to 90) 80 (60 to 90) 0.612
Co-morbidities and therapies on admission
COPD 260 (23%) 197 (22.8%) 63 (23.8%) 0.742
Chronic renal failure 40 (3.5%) 34 (3.9%) 6 (2.3%) 0.198
Diabetes 178 (15.8%) 145 (16.8%) 33 (12.5%) 0.091
Liver disease 48 (4.3%) 34 (3.9%) 14 (5.3%) 0.341
Chemotherapy 72 (6.4%) 48 (5.6%) 24 (9.1%) 0.041
Radiotherapy 4 (0.4%) 3 (0.3%) 1 (0.4%) 0.942
Mechanical Ventilation on ICU admission 388 (34.4%) 251 (29.1%) 137 (51.7%) ,0.001
Dialysis on ICU admission 45 (4%) 18 (2.1%) 27 (10.2%) ,0.001
Vasopressors on ICU admission 341 (30.2%) 195 (22.6%) 146 (55.1%) ,0.001
ICU stay (days), median (IQR) 4 (3 to 8) 3 (2 to 6) 6 (2 to 10) ,0,001
Abbreviations: 95% CI, 95% confidence interval; IQR, interquartile range; APACHE, Acute Physiology and Chronic Health disease; SAPS, Simplified Acute
Physiology Score; COPD, chronic obstructive pulmonary disease; ICU, intensive care unit. Parenthesis: % or CI or IQR.
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The variables which in the univariate anlaysis presented
p#0.10 were used to build the model.
A multiple Cox proportional hazards model was per-
formed to estimate predictive factors for hospital mortality.
Receiver operating characteristic (ROC) curves were built
for each variable to analyze its discriminating power in
predicting hospital mortality. The areas under the ROC
curves (¡SE) were determined.
In logistic regression model for other significant variables,
we built curves for each significant variable related to
hospital mortality.
A p-value of less than 0.05 was considered to indicate
statistical significance, and all tests were two-tailed.
RESULTS
Intensive Care Unit Mortality
Of a total of 2,653 patients admitted into the ICU during
the study period, 1,129 patients fulfilled the inclusion
criteria. Their characteristics are described in Table 1.
There were 854 ICU survivors (76.5%) and 265 ICU non-
survivors (23.5%) during the hospital stay. There were no
differences between the survivor and non-survivor groups
regarding age or gender. As expected, the non-survivor
group presented significantly higher APACHE II and SAPS
II scores compared to the survivor group.
A medical complication was the main reason for ICU
admission. Non-survivors were more likely to have a medical
diagnosis. There were 987 patients with solid tumors (87.4%)
while 142 patients (12.6%) had hematological malignancies.
The studied patients had a Karnofsky score of 80 (65-90).
Non-survivors were more likely to have received chemother-
apy in the last 30 days and in need of organ support at
admission. They also had longer ICU stay durations.
As shown in Figure 1, at the time of ICU admission (0 h),
the mean (CI) initial lactate concentrations were 2.4 [95% CI,
2.3 to 2.6] mmol/L in the survivors and 3.7 [95% CI, 3.3 to
4.1] mmol/L in the non-survivors (p,.001). After 24 h, the
lactate concentrations decreased to 1.8 [95% CI, 1.7 to 1.9]
mmol/L in the survivors but remained at 3.8 [95% CI, 3.3 to
4.3] mmol/L in the non-survivors (differences p,0.001).
Likewise, at baseline, the SBD was -3 [95% CI, -3.3 to -2.7]
mmol/L in the survivors and -5.7 [95% CI, -6.6 to -4.9]
mmol/L in the non-survivors (p,0.001). After 24 h, the SBD
increased to 2 mmol/L in the survivors while it increased to
0.8 mmol/L in the non-survivors (p,0.001). (Figure 1).
In a multivariate model, medical admission, RRT or
vasopressor therapy on ICU admission, 24 h lactate
Figure 1 - Comparison between survivor and non-survivor groups of A) lactate (mmol/L) and B) standard base deficit (SBD in mmol/L) in
two time points (0 and 24h). Mean +2 SEM (*) p,0.05 survivors versus non-survivors (#) p,0.05.
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.1.9 mmol/L and SBD between –10 and -4 mmol/L were
predictors of ICU mortality (Table 2).
Hospital Mortality
Of the 1,129 patients, 324 (28.7%) died during their
hospital stay. In an univariate analysis, higher APACHE II
and SAPS II scores, medical admissions, metastatic solid
tumors, hematological malignancies, mechanical ventilation
at ICU admission, and vasopressors at ICU admission were
associated with hospital mortality. Also, higher levels of
lactate at 0 h and 24 h and lower levels of SBD at 0 h and
24 h were associated with death during the hospital stay
(Figure 2 and Table 3).
Abbreviations: ICU, intensive care unit; SBD, Standard
base deficit iLactate values at 0 h and at 24 h that were
higher than 2.3 mmol/L and 1.9 mmol/L, respectively,
were observed to increase hospital mortality. Also, SBD
values at 0 h and at 24 h that were lower than -3.6 mmol/L
and -2.3 mmol/L was observed to increase hospital mor-
tality (Table 3).
From the ROC curves, the best predictors of hospital
mortality in critically ill cancer patients were lactate values
of greater than 2.3 mmol/L and a BD values lower than –
3.7 mmol/L at the time of admission. After 24 h, the best
predictors of ICU mortality were lactate values greater than
1.9 mmol/L and a BD values lower than – 2.3 mmol/L.
We graphically represented hospital survival curves for
each parameter (Figure 3).
In a multivariate model, medical admission, metastatic
solid tumor or hematological malignancies, 24 h lactate
values higher than 1.9 mmol/L and 24 h SBD values lower
than -2.3 mmol/L were the independent predictors of
hospital death (Table 4).
DISCUSSION
This is the first study showing that lactate and standard
base deficit levels are predictors of ICU and hospital
mortality in patients with cancer admitted to intensive care
units. In these patients with cancer, admission as well as
24 h lactate and SBD values can be used earlier and more
accurately than other variables to identify patients who have
a high risk for mortality.
Moreover, our data suggest that these variables are more
sensible and specific in their capacity to predict mortality in
a mixed population of medical and surgical patients with
cancer, 24 h after initial admission to the ICU.
Recently, patients with cancer are experiencing increased
survival rates, leading to increases in the number of ICU
admissions.15 Such findings highlight the need to better
characterize patients with cancers and to evaluate the
prognoses at ICU admission.
Larche´ and colleagues described a third-day mortality of
65.5% in 84 patients with cancer and septic shock.2 In a report
by Soares and colleagues, hospital mortality was 58% in cancer
patients admitted due to medical complications and 37% in
patients admitted after elective surgery.1 Our patients were
severely ill, with a median SAPS II score of 38. Most were
admitted due to sepsis or septic shock while a large percentage
of patients had metastatic solid tumors or hematological
cancers. Despite this, the overall ICU mortality rate in our
study was 24%; 37% in medical patients and 7% in surgical
Figure 2 - Receiver Operating Characteristic (ROC) curve
comparing the ability of A) lactate (mmol/L), B) standard base
deficit (SBD in mmol/L) at baseline and after 24 and C) SAPS II
SCORE after 24h in predicting ICU mortality.
Table 2 - Multiple logistic regression to determine
predictive factors for ICU mortality.
Variable Odds ratio 95%CI p-value
Medical admission 4.216 2.761 6.436 ,0.001
RRT on ICU admission 4.212 1.848 9.602 0.001
Vasopressors on ICU
admission
3.049 2.077 4.477 ,0.001
SBD (mmol/L) - 24 h ,0.001
,-2.3 2.400 1.635 3.523 ,0.001
.-2.3 Reference ,0.001
Lactate (mmol/L) - 24 h ,0.001
,1.9 Reference
.1.9 4.018 2.704 5.972 ,0.001
Abbreviations: ICU, intensive care unit; SBD, Standard base deficit in
mmol/L; RRT, renal replacement therapy.
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patients. Compared to the survivors, non-survivors presented
with higher lactate levels and lower base deficit levels at
admission and at 24 h. These findings are similar to the results
of previous studies assessing lactate, lactate clearance and base
deficits in critically ill patients.16-18 A high single lactate level
and limited lactate reduction during treatment have prognos-
tic importance.
Smith and colleagues showed in 148 patients without
cancer that both the base deficit and arterial lactate at
admission have good prognostic abilities.17 The value of
base deficit at the time of admission with the best predictive
ability was a base deficit value of less than –4 mmol/L and a
lactate value of greater than 1.5 mmol/L.
Nguyen and colleagues evaluated 111 septic patients and
found that lactate values at admission are higher in non-
survivors. Both lactate and lactate clearance are predictors
of mortality in these patients.5 In a recent study, Khosravani
and colleagues evaluated 11,581 patients and demonstrated
that hyperlactatemia is common in both medical and
surgical critically ill patients. Its presence at presentation
or its development during ICU stay is associated with
mortality.18 In our patients, lactate and SBD values at ICU
admission were risk factors and 24 h lactate and SBD values
were independent predictors of ICU and hospital mortality.
These data suggest the addition of low cost markers to
Figure 3 - Survival curves for type of admission, type of cancer and levels of lactate (mmol/L) and SBD (mmol/L) at 24h.
Table 3 - Univariate Cox proportional hazard analysis
with hospital mortality as the dependent variable.
Variable HR 95%CI p-value
Lactate (mmol/L)
0 h ,0.001
,2.3 (mmol/L) reference
.2.3 (mmol/L) 2.030 1.615 2.552 ,0.001
24 h ,0.001
,1.9 (mmol/L) reference
.1.9 (mmol/L) 3.262 2.502 4.252 ,0.001
SBD (mmol/L)
0 h ,0.001
,-3.6 2.170 1.727 2.726 ,0.001
.-3.6 reference
24 h ,0.001
,-2.3 2.448 1.909 3.138 ,0.001
.-2.3 reference
Abbreviations: ICU, intensive care unit; SBD, Standard base deficit in
mmol/L.
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existing routine evaluations of cancer patients admitted to
the ICU. Also, our findings highlight the importance of
immediate and adequate treatments of these patients, as the
serial improvement of these parameters is associated with a
better prognosis.
As stated in previous studies, usual risk scores in critically
ill patients such as SAPS II, APACHE II, SOFA, and MPM
scores do not apply well in patients with cancer.2 These
patients now live longer and present with higher rates of ICU
admission, which reinforces the need for more sensible and
specific parameters to evaluate patient prognosis.
In patients with cancer, it is important to emphasize that
increased lactate levels may be due to causes other than
tissue hypoxia liver disorders, lactate production by
neoplastic cells, tumor lysis syndrome, or compromises in
lactate clearance.19
A limitation of this study was that the study was
performed in a single referral center, which could limit the
generalizability of our findings. Another limitation is that
we did not specifically address other causes for the high
levels of lactate and the low levels of base deficit.
The addition of lactate and standard base deficit
measurement at ICU admission may represent a new issue
in the prognostic evaluation of cancer patients.
Our findings suggest the importance of the inclusion of
lactate and base deficit measurements in the assessment of
prognosis in cancer patients admitted to intensive care unit
with sepsis, septic shock, or after high-risk surgery. More
evidence is needed to clarify whether targeted therapy
through lactate and base deficit level measurements can
improve outcomes in cancer patients.
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